Inflammatory Liver Panel

Why It Matters

The Inflammatory Liver Panel evaluates autoimmune-related liver inflammation associated with conditions that may progressively damage the liver and bile ducts over time. Early detection of autoimmune liver disease is critical because symptoms may remain subtle until significant liver injury has already occurred. Identifying these markers early can support timely treatment and help slow disease progression.

Who Should Get It

Recommended for individuals with unexplained elevated liver enzymes, chronic fatigue, itching, abnormal liver function tests, autoimmune disease history, or family history of autoimmune liver disorders. It is also useful for patients with suspected inflammatory or cholestatic liver conditions.

How This Panel Is Used

Physicians use the Inflammatory Liver Panel to evaluate suspected autoimmune liver disease, investigate unexplained liver abnormalities, and support early detection of conditions affecting bile ducts and liver function. It is commonly ordered during hepatology, autoimmune, and metabolic evaluations.

What’s Included

This panel includes biomarkers associated with autoimmune-mediated bile duct and liver inflammation, supporting evaluation of inflammatory liver disease and early immune-related hepatic dysfunction.

Anti-Mitochondrial Antibody (AMA-M2), IgG

This test detects antibodies directed against mitochondrial M2 antigens, which are strongly associated with autoimmune liver disease, particularly Primary Biliary Cholangitis (PBC).

Diagnostic Value: The presence of M2 antibodies is highly specific for PBC, an autoimmune condition that causes gradual destruction of the bile ducts within the liver.

Clinical Significance: Early detection allows for timely management to slow disease progression and prevent complications such as cirrhosis or liver failure. M2 testing also helps differentiate PBC from other causes of cholestatic liver injury.

Symptom Correlation: Patients may present with persistent fatigue, itching (pruritus), jaundice, or right-upper-quadrant discomfort — symptoms reflecting bile duct inflammation and impaired liver function.

Because of its strong disease specificity, the Mitochondria (M2) Antibody IgG test is essential for confirming autoimmune liver disease and guiding early intervention.

Together, these biomarkers provide focused insight into autoimmune-related liver inflammation, supporting earlier detection and more informed management of progressive liver disease.